Cagan G.

Cagan G. has an extensive work experience in the biotechnology and pharmaceutical industries. Cagan is currently serving as the Vice President of Discovery at TScan Therapeutics since 2021. Prior to this, they worked at Kite Pharma as the Executive Director of Cell Therapy and TCR Discovery Research from 2019 to 2021. In this role, they were responsible for developing TCR-based adoptive cell therapy strategies for solid tumor indications and played a key role in developing Kite's solid tumor research and business development strategies.

Before their time at Kite Pharma, Cagan G. worked at Regeneron Pharmaceuticals, Inc. for over a decade. During their tenure, they held various positions including Senior Director, Director, Associate Director, Senior Staff Scientist, and Staff Scientist. In these roles, they made significant contributions to immune technology development, antibody and T-cell-based therapeutics for autoimmune and immuno-oncology indications, and the development and validation of technology platforms responsible for producing fully human monoclonal antibodies and therapeutic T-cell receptors.

Cagan G. also has experience in academia, having worked as a Postdoctoral Associate at Rockefeller University and as a Graduate Student at Columbia University Medical Center. During their postdoctoral work, they focused on studying the interaction of HIV viral proteins with cellular factors and developed a mouse with a humanized immune system to study EBV infection and develop a dendritic cell targeted vaccine.

Overall, Cagan G. has a diverse range of experience in immune technology, cell therapy, antibody development, TCR discovery, and preclinical research.

Cagan G. began their education in 1986 at the American Collegiate Institute (ACI) / Özel İzmir Amerikan Koleji. However, no specific degree or field of study is provided for this period. Cagan then went on to attend Ohio Wesleyan University from 1993 to 1997, where they earned a Bachelor of Arts degree in Biology. Finally, they pursued higher education at Columbia University Graduate School of Arts and Sciences from 1997 to 2004, specializing in Microbiology, and obtaining a Ph.D. degree.